INDRAMEDCO

Nov 1 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• DISCLOSURE REGARDING MEDIA ALLEGATIONS CONCERNING AN ASSOCIATE DOCTOR

• ALLEGED IRREGULARITIES ON KIDNEY TRANSPLANT PRACTICES NOT AT OUR HOSPITAL

Source text: ID:nBSE2wrzBS

Further company coverage: IMCL.NS

(([email protected];;))

Oct 30 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• SEPT-QUARTER PAT 424 MILLION RUPEES

• SEPT-QUARTER REVENUE FROM OPERATIONS 3.5 BILLION RUPEES

Source text: ID:nBSEvh0lx

Further company coverage: IMCL.NS

(([email protected];;))

** Shares of Indraprastha Medical Corp IMCL.NS jump as much as 20% to hit a record high of 262.80 rupees

** Co on Monday reported ~47% jump in Q1 profit, while rev rose 13.5% y/y

** IMCL stock is top gainer among hospital-related shares, up 75% YTD

** Shares of peers Max Healthcare MAXE.NS up 26%, Rainbow Children's RAIB.NS up 1%, Fortis Healthcare FOHE.NS up 23%, Narayana Hrudayalaya NARY.NS up 4%, while Apollo Hospital APLH.NS up 17% YTD

(Reporting by Sethuraman NR in Bengaluru)

(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))

** Shares of hospital chain Aster DM Healthcare ATRD.NS rise 5.3% to 365 rupees

** Co on Wednesday reported 81% surge in Q1 profit, on higher bed occupancy rates

** ATRD up 17% YTD; Fortis Healthcare FOHE.NS rises 20%, Indraprastha Medical Corp IMCL.NS surges 55%, Max Healthcare MAXE.NS climbs 34%, Apollo Hospitals APLH.NS rises 16%

** ATRD, FOHE, MAXE & APLH "buy" rated on avg; IMCL not rated - LSEG

(Reporting by Sethuraman NR in Bengaluru)

(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))

May 17 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• INDRAPRASTHA MEDICAL CORPORATION LTD - DIVIDEND 4.5 RUPEESPER SHARE

• INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER PAT 311.7 MILLION RUPEES VERSUS 198.4 MILLION RUPEES

• INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER REVENUE FROM OPERATIONS 3.15 BILLION RUPEES VERSUS 2.74 BILLION RUPEES

Source text for Eikon: ID:nBSE83P0Vk

Further company coverage: IMCL.NS

(([email protected];))

** Shares of healthcare firm Indraprastha Medical Corp IMCL.NS rise as much as ~20% to hit record high, last up 17%

** Stock up 42% for the week - biggest weekly gain in at least 10 yrs, per available LSEG data

** Reuters could not immediately ascertain the reason for stock move

** Stock on track to log steepest intraday gains since June 9, 2021

** Sees busiest trading day since May 5, 2021; volumes at 17.5x 30-day avg

** Including session's gains, stock up 41% YTD

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

Feb 6 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER PAT 294.4 MILLION RUPEES VERSUS PROFIT 209 MILLION RUPEES

• INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER REVENUE FROM OPERATIONS 3.06 BILLION RUPEES VERSUS 2.77 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: IMCL.NS

(([email protected];))

Corrects 3rd bullet to clarify that the Telegraph report said Apollo was embroiled in a "cash for kidneys" racket; removes reference to Apollo Hospitals Group enticing young villagers from Myanmar to sell their kidneys to rich patients around the world

** Shares of Indraprastha Medical Corporation IMCL.NS extend losses from the previous session to trade down as much as 5% at 189.95 rupees

** IMCL, which manages two Apollo APLH.NS hospitals in Delhi, denied allegations of its involvement in illegal kidney transplants

** UK's Telegraph newspaper reported on Saturday that Apollo was embroiled in a "cash for kidneys" racket in which impoverished people from Myanmar were being enticed to sell their organs for profit

** IMCL says has initiated inquiry into all aspects of the transplant process

** More than 245,000 shares change hands, 1.7x their 30-day avg

** APLH last down 0.3%; IMCL shares have more than doubled YTD, while APLH has risen 24%

(Reporting by Rama Venkat in Bengaluru)

(([email protected]; https://twitter.com/ramavenkat0607;))

Dec 5 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• VEHEMENTLY DENIES SUGGESTION OF WILLFUL COMPLICITY OR IMPLICIT SANCTIONING OF ILLEGAL ACTIVITIES RELATING TO ORGAN TRANSPLANTS

• IMCL INITIATED INQUIRY INTO MATTER TO DELVE INTO ALL ASPECTS OF TRANSPLANT PROCESS

• IMCL DOES NOT SEEK UNRELATED DONORS NOR ITS REPRESENTATIVES ARE AUTHORIZED TO FIND UNRELATED DONORS FOR KIDNEY PATIENTS

Source text for Eikon: ID:nBSE6x4Cyk

Further company coverage: IMCL.NS

(([email protected];))

Nov 3 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER PAT 328.5 MILLION RUPEES VERSUS 251.3 MILLION RUPEES

• INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER REVENUE FROM OPERATIONS 3.17 BILLION RUPEES VERSUS 2.84 BILLION RUPEES

Source text for Eikon: ID:nBSE6zZvpH

Further company coverage: IMCL.NS

(([email protected];))

Aug 4 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• INDIA'S INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER PAT 305 MILLION RUPEES VERSUS PROFIT 202.8 MILLION RUPEES

• INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER REVENUE FROM OPERATIONS 3.07 BILLION RUPEES VERSUS 2.63 BILLION RUPEES

Source text for Eikon: ID:nNSE2t0MZR

Further company coverage: IMCL.NS

(([email protected];;))

May 23 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:

• MARCH-QUARTER PAT 198.4 MILLION RUPEES VERSUS 152 MILLION RUPEES

• MARCH-QUARTER REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 2.16 BILLION RUPEES

• DIVIDEND 3 RUPEES PER SHARE

Source text for Eikon: ID:nBSEc2y8nY

Further company coverage: IMCL.NS

(([email protected];))